期刊
CHROMATOGRAPHIA
卷 55, 期 -, 页码 S171-S175出版社
SPRINGER HEIDELBERG
DOI: 10.1007/BF02493375
关键词
column liquid chromatography; photodynamic therapy; human and rat plasma; stability studies; method validation
A well characterised and fully validated bioanalytical method used for measuring a novel porphyrin photodynamic therapy (Compound I) in human plasma was modified in order to enable the measurement of a structurally and metabolically related compound (Compound II) in rat plasma. The modified method was validated, but after initial attempts to implement the method to support routine sample analysis failed, it was suspected that Compound II was unstable in rat plasma. The preparation of plasma Quality Control (QC) samples used during validation to evaluate precision, inaccuracy, stability and the on-going performance of the method, was closely scrutinised because of the limited solubility of this class of compound in aqueous solution. After investigating the solvent composition of standard solutions of Compound II used during the preparation of QCs, together with the subsequent mixing techniques used to distribute the analyte in plasma, the limited solubility of Compound II was eventually shown to be the cause of the stability problem.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据